Renal Cell Cancer Treated with a Single-Edged Sword

Emerson Lim, Edward P. Gelmann

Research output: Contribution to journalShort surveypeer-review


Preclinical and early clinical data suggest that antiangiogenic treatments may lead to more aggressive tumors. In this issue of Cell Reports, Blagoev et al. (2013) show that sunitinib, a multikinase inhibitor with antiangiogenic effects, does not worsen the survival of patients with metastatic kidney cancer.

Original languageEnglish (US)
Pages (from-to)275-276
Number of pages2
JournalCell Reports
Issue number2
StatePublished - 2013
Externally publishedYes

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)


Dive into the research topics of 'Renal Cell Cancer Treated with a Single-Edged Sword'. Together they form a unique fingerprint.

Cite this